Archive for August 29, 2019

Clinical Klebsiella pneumoniae Isolate with Three Carbapenem Resistance Genes Associated with Urology Procedures – King County, Washington, 2018.

MMWR Morb Mortal Wkly Rep. 2019 Aug 2;68(30):667-668.

Vannice K, Benoliel E, Kauber K, Brostrom-Smith C, Montgomery P, Kay M, Walters M, Tran M, D’Angeli M, Duchin J.

PDF

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677168/pdf/mm6830a4.pdf

August 29, 2019 at 6:12 pm

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa.

Clin Infect Dis. March 21, 2019 pii: ciy1121. doi: 10.1093/cid/ciy1121. [Epub ahead of print]

Nicolle LE1, Gupta K2, Bradley SF3, Colgan R4, DeMuri GP5, Drekonja D6, Eckert LO7, Geerlings SE8, Köves B9, Hooton TM10, Juthani-Mehta M11, Knight SL12, Saint S13, Schaeffer AJ14, Trautner B15, Wullt B16, Siemieniuk R17.

Author information

1 Department of Internal Medicine, School of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.

2 Division of Infectious Diseases, Veterans Affairs Boston Healthcare System and Boston University School of Medicine, West Roxbury, Massachusetts.

3 Division of Infectious Diseases, University of Michigan, Ann Arbor.

4 Department of Family and Community Medicine, University of Maryland, Baltimore.

5 Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison.

6 Division of Infectious Diseases, University of Minnesota, Minneapolis.

7 Department of Obstetrics and Gynecology and Department of Global Health, University of Washington, Seattle.

8 Department of Internal Medicine, Amsterdam University Medical Center, The Netherlands.

9 Department of Urology, South Pest Teaching Hospital, Budapest, Hungary.

10 Division of Infectious Diseases, University of Miami, Florida.

11 Division of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.

12 Library and Knowledge Services, National Jewish Health, Denver, Colorado.

13 Department of Internal Medicine, Veterans Affairs Ann Arbor and University of Michigan, Ann Arbor.

14 Department of Urology, Northwestern University, Chicago, Illinois.

15 Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas.

16 Division of Microbiology, Immunology and Glycobiology, Lund, Sweden.

17 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Abstract

Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be screened for and treated only in pregnant women or in an individual prior to undergoing invasive urologic procedures. Treatment was not recommended for healthy women; older women or men; or persons with diabetes, indwelling catheters, or spinal cord injury. The guideline did not address children and some adult populations, including patients with neutropenia, solid organ transplants, and nonurologic surgery. In the years since the publication of the guideline, further information relevant to ASB has become available. In addition, antimicrobial treatment of ASB has been recognized as an important contributor to inappropriate antimicrobial use, which promotes emergence of antimicrobial resistance. The current guideline updates the recommendations of the 2005 guideline, includes new recommendations for populations not previously addressed, and, where relevant, addresses the interpretation of nonlocalizing clinical symptoms in populations with a high prevalence of ASB.

FULL TEXT

https://academic.oup.com/cid/article/68/10/e83/5407612

PDF (CLIC PDF)

August 29, 2019 at 6:10 pm

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.

MMWR Morb Mortal Wkly Rep. August 16, 2019 V.68 N.32 P.698-702.

Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE.

Abstract

Vaccination against human papillomavirus (HPV) is recommended to prevent new HPV infections and HPV-associated diseases, including some cancers.

The Advisory Committee on Immunization Practices (ACIP)* routinely recommends HPV vaccination at age 11 or 12 years; vaccination can be given starting at age 9 years.

Catch-up vaccination has been recommended since 2006 for females through age 26 years, and since 2011 for males through age 21 years and certain special populations through age 26 years.

This report updates ACIP catch-up HPV vaccination recommendations and guidance published in 2014, 2015, and 2016 (1-3). Routine recommendations for vaccination of adolescents have not changed. In June 2019, ACIP recommended catch-up HPV vaccination for all persons through age 26 years.

ACIP did not recommend catch-up vaccination for all adults aged 27 through 45 years, but recognized that some persons who are not adequately vaccinated might be at risk for new HPV infection and might benefit from vaccination in this age range; therefore, ACIP recommended shared clinical decision-making regarding potential HPV vaccination for these persons.

FULL TEXT

https://www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm?s_cid=mm6832a3_w

PDF

https://www.cdc.gov/mmwr/volumes/68/wr/pdfs/mm6832a3-H.pdf

 

August 29, 2019 at 10:54 am


Calendar

August 2019
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Posts by Month

Posts by Category